Skip to main content

Surgery for End-Stage Heart Disease and Heart Transplantation

  • Chapter
  • First Online:
Evidence-Based Practice in Perioperative Cardiac Anesthesia and Surgery
  • 1430 Accesses

Abstract

End-stage heart disease can be a result of idiopathic cardiomyopathy, chronic ischemic damage or long-standing volume or pressure overload from valvular pathology. While cardiac transplantation may be the ultimate therapy for the fortunate patient who is eligible, conventional surgical interventions can be considered in highly selected cases. This chapter reviews the current evidence supporting the decision to provide high risk conventional surgery and summarizes the current indications and results of heart transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mehra MR, Canter CE, Hannan MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for Heart Transplantation: a 10 year update. J Heart Lung Transplant. 2016;35:1–23.

    Article  PubMed  Google Scholar 

  2. Kawajiri H, Manlhiot C, Ross H, et al. High risk cardiac surgery as an alternative to transplant or mechanical support in patients with end-stage heart failure. J Thorac Cardiovasc Surg. 2017;154:517–25.

    Article  PubMed  Google Scholar 

  3. Doenst T, Velazquez EJ, Beyersdorf F, et al. The STICH Investigators. To STICH or not TO STICH—We know the answer, but do we understand the question? J Thorac Cardiovasc Surg 2005; 129: 246-249

    Google Scholar 

  4. Jones RH, Velazquez EJ, Michler RE, et al. The STICH Investigators. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009;360:1705–1171

    Google Scholar 

  5. Velazquez EJ, Lee KL, Deja M, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364:1607–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Velazquez EJ, Lee KL, Jones RH, et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374:1511–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bonow RO, Maurer JG, Lee KL, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Panza JA, Holly TA, Asch FM, et al. Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 2013;61:1860–70.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Romano MA, Bolling SF. An update on mitral repair in dilated cardiomyopathy. J Card Surg. 2004;19:396–400.

    Article  PubMed  Google Scholar 

  10. Michler RE, Smith PK, Parides MK, et al. Two year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374:1932–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374:344–35.

    Google Scholar 

  12. Athanasuleas CL, Buckberg GD, Stanley AW, et al. Surgical ventricular restoration: The Restore Group Experience. Heart Fail Rev. 2004;9:287–97.

    Article  PubMed  Google Scholar 

  13. Dor V, Saab M, Coste P, Kornaszewska M, Montiglio F. Left ventricular aneurysm: a new surgical approach. Thorac Cardiovasc Surg. 1989;37:11–9.

    Article  CAS  PubMed  Google Scholar 

  14. Mickleborough LL, Merchant N, Ivanov J, Rao V, Carson S. Left ventricular reconstruction: early and late results. J Thorac Cardiovasc Surg. 2004;128:27–37.

    Article  PubMed  Google Scholar 

  15. Michler RE, Rouleau JL, Al-Khalidi HR, et al. Insights from the STICH trial: change in ventricular size after coronary artery bypass grafting with or without surgical ventricular reconstruction. J Thorac Cardiovasc Surg. 2013;146:1139–45.

    Article  PubMed  Google Scholar 

  16. Dhital KK, Iyer A, Connellan M, et al. Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series. Lancet. 2015;385:2585–91.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vivek Rao .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rao, V. (2021). Surgery for End-Stage Heart Disease and Heart Transplantation. In: Cheng, D.C., Martin, J., David, T. (eds) Evidence-Based Practice in Perioperative Cardiac Anesthesia and Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-47887-2_46

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-47887-2_46

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-47886-5

  • Online ISBN: 978-3-030-47887-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics